Screener
Vera Therapeutics VERA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
FAQ
- What is Vera Therapeutics's free cash flow?
- Vera Therapeutics (VERA) reported free cash flow of -$106.52M in Q1 2026.
- How has Vera Therapeutics's free cash flow changed year-over-year?
- Vera Therapeutics's free cash flow decreased by 95.1% year-over-year, from -$54.59M to -$106.52M.
- What is the long-term trend for Vera Therapeutics's free cash flow?
- Over 4 years (2021 to 2025), Vera Therapeutics's free cash flow has grown at a 78.7% compound annual growth rate (CAGR), from -$23.71M to -$241.73M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Vera Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude